This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Perkinelmer Biosignal, Inc., Perkinelmer Health Sciences, Inc.. Active years: 2012.
Company Filing History:
1 out of 2 
1 out of 296 
Years Active: 2012
Title: Lucille Beaudet: Innovator in Glycogen Synthase Kinase Research
Introduction
Lucille Beaudet is a notable inventor based in Varennes, CA. She has made significant contributions to the field of glycogen synthase kinase research, holding 2 patents that focus on innovative assay methods and kinase substrates.
Latest Patents
Her latest patents include "Assay methods for identifying glycogen synthase kinase 3 modulators" and "Kinase substrates." The first patent addresses the need for methods and compositions that facilitate the detection of glycogen synthase kinase 3, assess its activity, and identify potential modulators. This work is based on the discovery of a novel interaction between glycogen synthase kinase 3 and eukaryotic translation initiation factor 4E-binding protein 1. The second patent describes tyrosine kinase substrates that are chemically stable and can be phosphorylated by various tyrosine kinases, providing valuable tools for further research.
Career Highlights
Lucille has worked with reputable companies such as PerkinElmer Biosignal, Inc. and PerkinElmer Health Sciences, Inc. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Throughout her career, Lucille has collaborated with esteemed colleagues, including Roberto J Rodriguez-Suarez and Mireille Caron. These partnerships have enriched her work and fostered innovation in her field.
Conclusion
Lucille Beaudet's contributions to glycogen synthase kinase research exemplify her dedication to innovation and scientific advancement. Her patents and collaborations highlight her impact on the field and the importance of her work in developing new methodologies.